[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$ovid](/topic/$ovid)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ovid/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ovid/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +65%  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-09-16  

**Most Supportive Themes**
- **Positive Analyst Ratings and Price Targets:** (30%) Oppenheimer initiated coverage with an Outperform rating and a $X price target, and B. Riley raised Ovid Therapeutics target to $X from $X Buy.
- **Bullish Sentiment and Trading Community Activity:** (25%) Many posts highlight positive sentiment, with traders sharing gains and recommending OVID, and a strong trading community is actively discussing and promoting the stock.
- **Positive Data and Catalysts:** (20%) Mentions of positive data from OV329 and OV350, along with a recent $175M PIPE raise, are driving positive sentiment.
  
**Most Critical Themes**
- **Market Volatility and Portfolio Performance:** (10%)  Some posts mention that the portfolio took a beating, and the stock is in the red, indicating potential market volatility.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | XX% |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | XX% |